weight loss drug prescriptions semaglutide tirzepatide q3 2024 data 💉 Americans Spent $40 Billion on Drugs in 2023 GLP-1 Weight Loss Drug Market

Preclinical non-human primate data claims 5 / 4 / 4 greater potency than retatrutide at GLP-1R / GIPR / GCGR

The peptide repairs intestinal mucosal damage, restores tight junction integrity, normalizes gastric emptying, protects against NSAID-induced ulcers, and promotes healing of inflammatory lesions

Trulicity (dulaglutide) is a GLP-1 receptor agonist that does not cause physical dependence or withdrawal symptoms when stopped suddenly

2020;2:vdaa131

Insurance coverage of GLP-1 medications for obesity has invariably been relatively meager across all markets, from commercial to Medicaid to Medicare

This is particularly relevant in regions with significant temperature variations or in situations where the medication might be moved between different storage locations